Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Endocrinol Invest ; 34(7 Suppl): 18-22, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21985975

RESUMO

The aim of this review is to focus on the roles of PTH in bone remodeling. PTH plays a central role in regulating calcium-phosphate metabolism and its production increases in response to low serum calcium levels. A continue hypersecretion of PTH, as occurs in primary hyperparathyroidism, leads to bone resorption. On the other hand, there is clear evidence of the anabolic properties of PTH.When administered at a low dose and intermittently, this hormone seems to be able to exert positive effects on bone volume and microarchitecture. The effects of PTH are mediated by PTH/PTH-related protein receptor, a G protein that can activate the cAMP-dependent protein kinase (PK)A and calcium-dependent PKC; the activation of PKA account for most of the PTH anabolic action. The anabolic actions of PTH involve direct effects on osteoblasts and indirect effects mediated by activation of skeletal growth factors (IGF-I) and inhibition of growth factor antagonists, such as sclerostin. PTH enhances the number and the activation of osteoblast through 4 pathways: increasing osteoblast proliferation and differentiation, decreasing osteoblast apoptosis and reducing the negative effects of peroxisome proliferator activator (PPAR)γ receptor on osteoblast differentiation. Moreover PTH enhances the Wnt-ß catenin pathway, that is central to osteogenesis and bone formation, inhibiting sclerostin. Finally, PTH induces the synthesis of IGF-I and, due to its prodifferentiating and pro-survival effects on osteoblasts, this could be a key mediator of PTH effect on osteoblasts. In conclusion, the intermittent administration of PTH has a pleiotropic anabolic effect on bone; further studies about mechanisms of action of PTH could be a starting point to new osteoporosis treatments.


Assuntos
Anabolizantes/farmacologia , Remodelação Óssea/efeitos dos fármacos , Osteoblastos/efeitos dos fármacos , Hormônio Paratireóideo/fisiologia , Animais , Proteínas Morfogenéticas Ósseas/antagonistas & inibidores , Osso e Ossos/metabolismo , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Humanos , Fator de Crescimento Insulin-Like I/biossíntese , Fator de Crescimento Insulin-Like I/metabolismo , Hormônio Paratireóideo/administração & dosagem , Proteína Quinase C/metabolismo , Receptor Tipo 1 de Hormônio Paratireóideo/metabolismo , Via de Sinalização Wnt/efeitos dos fármacos , beta Catenina/metabolismo
2.
Minerva Med ; 75(17): 967-74, 1984 Apr 21.
Artigo em Italiano | MEDLINE | ID: mdl-6728250

RESUMO

When considering urogenital complaints occurring during diabetic autonomous neurotherapy , three clinical situations are important due to their frequency and the clinical situation, the considerable effect they have on quality of life. In addition they may also be responsible for severe complications as in the case of diabetic cystopathy . This syndrome is the cause of considerable subjective disturbances even though it may be diagnosed instrumentally in its early, completely asymptomatic stage. The complaint evolves inevitably towards bladder denervation, chronic urinary retention and more or less severe septic complications. Retrograde ejaculation may lead to the loss of procreative ability as in the case of neurogenic impotence in diabetics. These three autonomous neuropathic situations occur quite frequently, especially in older subjects who have suffered from diabetes for more than ten years. Often the three syndromes are interconnected or linked to autonomous or peripheric neuropathic complaints affecting other areas. The few therapeutic measures practised have not proved very conclusive. Only a diligent examination of signs and symptoms with the aim of early diagnosis and the maintenance of good glycometabolic balance are considered to be at all effective as preventive measures.


Assuntos
Neuropatias Diabéticas/patologia , Bexiga Urinaria Neurogênica/complicações , Adulto , Idoso , Diabetes Mellitus Tipo 1/complicações , Disfunção Erétil/etiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Cateterismo Urinário , Incontinência Urinária/etiologia , Transtornos Urinários/etiologia , Transtornos Urinários/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA